Clinuvel Pharmaceuticals | CUV - Operating Profit

Stock Price
11.03
Daily Change
-0.70 -5.97%
Monthly
-10.03%
Yearly
-3.84%
Q1 Forecast
10.78

Clinuvel Pharmaceuticals reported AUD39.05M in Operating Profit for its fiscal semester ending in June of 2024.





Operating Profit Change Date
Avita Medical AUD -11.15M 1.19M Jun/2025
Medical Developments International AUD -480K 662K Jun/2025
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
PYC Therapeutics AUD -13.47M 12.42M Jun/2025
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024